EGFR and neoplasm: There were 38 patients (42.70%) harboring mutant EGFR gene in their tumor tissues, including 16 cases of exon 19 deletion, 18 cases of exon 21 L858R missense mutation, and 4 cases of exon 20 T790M mutation.